"Nivolumab With Ipilimumab Combination Added Benefit Advanced Renal∨derfield=date∨derval=DESC" News Stories

00:18 EDT 19th July 2019 | BioPortfolio

Here are the most relevant search results for "Nivolumab With Ipilimumab Combination Added Benefit Advanced Renal∨derfield=date∨derval=DESC" found in our extensive news archives from over 250 global news sources.

More Information about Nivolumab With Ipilimumab Combination Added Benefit Advanced Renal∨derfield=date∨derval=DESC on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Nivolumab With Ipilimumab Combination Added Benefit Advanced Renal∨derfield=date∨derval=DESC for you to read. Along with our medical data and news we also list Nivolumab With Ipilimumab Combination Added Benefit Advanced Renal∨derfield=date∨derval=DESC Clinical Trials, which are updated daily. BioPortfolio also has a large database of Nivolumab With Ipilimumab Combination Added Benefit Advanced Renal∨derfield=date∨derval=DESC Companies for you to search.

Showing "Nivolumab With Ipilimumab Combination Added Benefit Advanced Renal" News Articles 1–25 of 11,000+

Thursday 18th July 2019

Anorexia redefined as both metabolic and psychiatric

A large-scale genome-wide association study, led by researchers at King’s College London and the University of North Carolina at Chapel Hill (UNC), suggests that anorexia nervosa is at least partly a metabolic disorder, and not purely psychiatric as previously thought. The groundbreaking results of the study have been published in the journal Nature Genetics. Anorexia nervosa is a serious and p...

IRS Notice, Newly Introduced Medicare Legislation Work to Expand Benefits of Health Savings Accounts for Millions of Americans

HealthEquity helps introduce legislation that would allow Medicare recipients to open and contribute to HSAs; IRS expands preventive care benefit options for chronic conditions HealthEquity, Inc. (NASDAQ: HQY), the nation’s largest independent health savings account (HSA) non-bank custodian, participated in drafting legislation announced today that along with a new IRS notice, will expand the...

Sensient Technologies Corporation Elects Carol Jackson to its Board of Directors

Sensient Technologies today announced the election of Carol Jackson to its Board of Directors, effective December 1, 2019. Ms. Jackson is Chairman, President, and Chief Executive Officer of Harbison Walker International, the largest supplier of ceramic refractories in the U.S. with operations in the U.S., Mexico, Europe, and Southeast Asia and commercial interests globally. The 150-year-old com...

Missing Teeth in Bridgeville, PA Replaced with Natural-Looking Dental Implants by DiBartola Dental

Dentists, Drs. Wayne DiBartola and Tyler Porco of DiBartola Dental, welcome patients seeking single dental implants without needing a referral. The practice can both place and restore implants and offers a comfortable patient experience through advanced technology and custom sedation dentistry. BRIDGEVILLE, Pa. (PRWEB) July 18, 2019 Patients with missing teeth are invited to DiBartola Dental with...

Manhattan Scientifics Announces Breakthrough Device for Detection of Cancer

Manhattan Scientifics Inc.’s (OTC: QB MHTX) former wholly-owned subsidiary that was initially funded by MHTX, Imagion Biosystems Ltd (ASX:IBX) over a nine-year period has received confirmation from the Food and Drug Administration (FDA) that the MagSense System and Test for staging

Investigators Seek to Boost Surgical Cures in RCC With Immune Priming

In the phase III PROSPER trial, investigators will attempt a novel approach in localized renal cell carcinoma: priming the immune system prior to nephrectomy with neoadjuvant nivolumab and continuing with adjuvant blockade. The study will be the first to combine neoadjuvant and adjuvant immunotherapy with standard of care nephrectomy.

Regorafenib/Nivolumab Combo to Be Explored in Phase III MSS CRC Trial

The combination of regorafenib and nivolumab will be compared with regorafenib alone in a phase III trial of patients with microsatellite stable colorectal cancer, following encouraging phase Ib findings of the REGONIVO study.

Support for Broadening ECG Criteria for Using CRT

It might be oversimplifying to focus only on heart failure patients with left-bundle-branch block, say some. There is a non-LBBB subgroup that seems to benefit, suggest registry data. Medscape Medical News

Society for Immunotherapy of Cancer Publishes First Clinical Immunotherapy Treatment Guidelines for Squamous Cell Carcinoma of the Head and Neck

The Society for Immunotherapy of Cancer (SITC) has published the first clinical immunotherapy treatment guidelines for squamous cell carcinoma of the head and neck (HNSCC), providing oncologists and other advanced practice providers a clinical roadmap to treating this disease with immunotherapies approved in the United States. “The Society for Immunotherapy of Cancer consensus statement on immun...

Sam’s Club® Is Partnering with Lucid Hearing® and Liberty Hearing Aids® to Provide the Latest Hearing Technology with Prices that Undercut National Competitors

Lucid Hearing is pleased to announce that Sam’s Club has the latest hearing technology that incorporates Bluetooth® communication to the iPhone® with Lucid® digital technology and is value priced at $1399.98 a pair. The U24 channel hearing aids include Lucid Clear™ advanced noise reduction and low-level and impulse noise suppression. Lucid Hearing is also introducing a pair of U16 channel ...

The American Journal of Managed Care® Adds Innovation and Value Initiative to Its Strategic Alliance Partnership Program

The American Journal of Managed Care® (AJMC®), the leading multimedia peer-reviewed journal dedicated to issues in managed care, has added Innovation and Value Initiative (IVI) to its Strategic Alliance Partnership (SAP) program. “IVI is committed to improving value assessment in health care through collaboration of leaders in all different areas of the health care landscape,” said Michae...

Most New Drugs Show No Evidence of Added Benefit

Most new drugs entering the market have shown no added benefit over the existing standard of care, with psychiatry and neurology drugs showing the worst numbers, new research suggests. Medscape Medical News

Steve English Joins Trustmark Board of Directors

Steven E. English, Senior Vice President and Chief Financial Officer, State Auto Group, has been elected to the Board of Directors of Trustmark Mutual Holding Company (Trustmark). The announcement was made by Trustmark Chairman David Weick. This press release features multimedia. View the full release here: E. English (Photo: Busines...

Using mathematical model to trace brain transitions

Unique in its application of a mathematical model to understand how the brain transitions from consciousness to unconscious behavior, a study at The City College of New York's Benjamin Levich Institute for Physico-Chemical Hydrodynamics may have just advanced neuroscience appreciably.

Young men 'benefit' in later years when teen pregnancy ends in abortion

When young women use abortion services, the adolescent men who avoid becoming teenaged fathers go on to have better educational and financial futures than peers who do become teen fathers, a U.S. study suggests.

Bayer, Bristol-Myers Squibb and Ono Collaborate to Investigate the Combination of Stivarga and Opdivo in Patients with Metastatic Colorectal Cancer

WHIPPANY, N.J. & PRINCETON, N.J. & OSAKA, Japan–(BUSINESS WIRE)–Bayer, Bristol-Myers Squibb Company (NYSE: BMY) and Ono Pharmaceutical Co., Ltd. (“Ono”) announced today the three companies have entered into a clinical collaboration agreement to evaluate the combination of Bayer’s kinase inhibitor Stivarga® (regorafenib) and Bristol-Myers Squibb’s / Ono’s anti-PD-1...

Blood Pressure Product Beats the Competition with 5-Star Rating from

Advanced Blood Pressure Formula, a leading Blood Pressure product offered by Advanced Bionutritionals, receives a best-in-class 5-star rating from OVERLAND PARK, Kan. (PRWEB) July 18, 2019 recently awarded their highest five-star rating to Advanced Blood Pressure Formula, an industry leader among products designed to maintain healthy Blood Pressure. ...

Phase II/III Study Trends and Market Outlook 2018-2022 –

DUBLIN–(BUSINESS WIRE)–The “Phase II/III Study Trends and Market Outlook (2018-2022)” report has been added to’s offering. Keeping up-to-date with the evolving pharmaceutical market is no easy task. The constant flow of newsletters hitting our inboxes is almost too much … Continue reading →

Bioprocessing Market Trends & Outsourcing Dynamics Report 2018-2023 –

DUBLIN–(BUSINESS WIRE)–The “Bioprocessing Market Trends & Outsourcing Dynamics: 2018-2023 (2nd Edition)” report has been added to’s offering. Bioprocessing Market Trends and Outsourcing Dynamics: 2018-2023 report affords readers the opportunity to gain insight into the bioprocessing market and where it’s … Continue reading ͛...

Combination of incompatible and sterile insect techniques enables near elimination of the invasive mosquito species, Aedes albopictus in the field  #NBTHighlight

Combination of incompatible and sterile insect techniques enables near elimination of the invasive mosquito species, Aedes albopictus in the field  #NBTHighlight

Philips Future Health Index 2019 Finds US Among Leaders In EMR Use and AI Spend, but Overall Digital Health Technology Adoption Mixed

Investment, benefit and opportunity high but misconceptions and interoperability challenge scaling of AI and telehealth; millennials reluctant to share digital data Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its U.S. Future Health Index (FHI) 2019 report, showing that wh

Corporate Update: Jacksam Corporation Announces Organizational Changes and Open Source Model to Enable the Majority of Cannabis and CBD Companies to Automate Post-extraction Processes

– Approach Broadens Market Reach and Adoption – Jacksam Corporation (OTCQB:JKSM) (the “Company” or “Jacksam/Convectium”), a workflow automation company focused on developing machinery and equipment solutions for the cannabis and CBD industry, announced today that the Company has adopted an “open source” business model enabling the majority of cannabis and CBD oil producers to ben...

ExpertPages® 2019 Survey Reports Expert Witness Hourly Fees Record All-Time Highs as Demand for Qualified Experts Continues to Grow

Expert witness work is in! That was evident today as, a unit of Advice CompanyTM, released the findings from its 2019 Expert Witness Fees & Practices Survey. With litigation of all types becoming increasingly complex, the demand and compensation for qualified and credentialed expert witnesses have now reached its highest level in the Survey’s 18-year history. More than 700...

VetStem Biopharma Enters Pet Cancer Field with Key License from Leading Human Cancer Company, Calidi Biotherapeutics

VetStem Biopharma has licensed a highly promising oncolytic virus cancer therapy platform from Calidi Biotherapeutics for use in veterinary medicine. POWAY, Calif. (PRWEB) July 18, 2019 VetStem Biopharma has long been a leader in veterinary stem cell therapy with clinical, regulatory and manufacturing experience. As a result of a two-year research collaboration with Calidi Biotherapeutics, VetS...

Titan Medical Completes Preclinical Good Laboratory Practice Procedures With Its Single-Port Robotic Surgical System

Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces that all procedures under Good Laboratory Practice (“GLP”) principles associated with the acute and chronic animal studies and human c...

Quick Search

News Quicklinks